Skip to main content
. 2017 May 5;7(1):101–106. doi: 10.5005/jp-journals-10018-1226

Table 6: Comparison between before and after treatment in group II as regards laboratory findings

     Group I          
Variables      Before treatment (n = 15)      After treatment (n = 15)      p-value     
Hemoglobin (g/dL)      13.57 ± 0.84      13.67 ± 0.71      0.355     
WBCs (× 103/mm3)      7.36 ± 1.85      7.36 ± 1.67      0.937     
Platelet count (× 103/mm3)      312.20 ± 75.56      309.26 ± 70.02      0.366     
Protein (g/dL)      7.45 ± 0.89      7.42 ± 0.80      0.362     
Albumin (g/dL)      4.64 ± 0.45      4.66 ± 0.41      0.519     
TSB (mg/dL)      0.86 ± 0.41      0.88 ± 0.37      0.340     
DSB (mg/dL)      0.12 ± 0.05      0.12 ± 0.05      0.582     
ALT (U/L)      83.53 ± 12.01      82.53 ± 10.41      0.096     
AST (U/L)      58.73 ± 9.95      55.86 ± 5.11      0.048     
Serum creatinine (mg/dL)      1.05 ± 0.30      1.07 ± 0.20      0.638     
BUN (mg/dL)      19.13 ± 7.46      18.46 ± 6.45      0.329     

WBC: While blood cell; TSB: Total serum bilirubin; DSB: Direct serum bilirubin; BUN: Blood urea nitrogen